Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-07T13:50:02.735Z Has data issue: false hasContentIssue false

Characteristics of Müller glial cells in MNU-induced retinal degeneration

Published online by Cambridge University Press:  17 October 2016

MIRIAM REISENHOFER
Affiliation:
Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland Paul Flechsig Institute of Brain Research, Medical Faculty, University of Leipzig, 04103 Leipzig, Germany Department of Clinical Research, University of Bern, 3008 Bern, Switzerland
THOMAS PANNICKE
Affiliation:
Paul Flechsig Institute of Brain Research, Medical Faculty, University of Leipzig, 04103 Leipzig, Germany
ANDREAS REICHENBACH
Affiliation:
Paul Flechsig Institute of Brain Research, Medical Faculty, University of Leipzig, 04103 Leipzig, Germany
VOLKER ENZMANN*
Affiliation:
Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland Department of Clinical Research, University of Bern, 3008 Bern, Switzerland
*
*Address correspondence to: Volker Enzmann, Department of Ophthalmology, Inselspital, Bern University Hospital, Freiburgstr. 14, 3010 Bern, Switzerland. E-mail: volker.enzmann@insel.ch
Rights & Permissions [Opens in a new window]

Abstract

Retinal Müller glial cells have been shown to undergo reactive gliosis in a variety of retinal diseases. Upregulation of glial fibrillary acidic protein (GFAP) is a hallmark of Müller cell activation. Reactive gliosis after retinal detachment or ischemia/reperfusion is characterized by hypertrophy and downregulation of inwardly rectifying K+ (Kir) currents. However, this kind of physiological alteration could not be detected in slowly progressing retinal degenerations. The photoreceptor toxin N-methyl-N-nitrosourea (MNU) leads to the rapid loss of cells in the outer nuclear layer and subsequent Müller cell activation. Here, we investigated whether Müller cells from MNU-treated mice exhibit reactive gliosis. We found that Müller cells showed increased GFAP expression and increased membrane capacitance, indicating hypertrophy. Membrane potential and Kir channel-mediated K+ currents were not significantly altered whereas Kir4.1 mRNA expression and Kir-mediated inward current densities were markedly decreased. This suggests that MNU-induced Müller cell gliosis is characterized by plasma membrane increase without alteration in the membrane content of Kir channels. Taken together, our findings show that Müller cells of MNU-treated mice are reactive and respond with a form of gliosis which is characterized by cellular hypertrophy but no changes in Kir current amplitudes.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2016 
Figure 0

Fig. 1. Quantification of photoreceptor nuclei in the ONL. Numbers of photoreceptor nuclei in the ONL were significantly decreased at d3, d5, and d7 when compared to numbers obtained from control samples (**; P < 0.01). A significant decrease was also evident between d3 and d5–d7 (**; P < 0.01). Data are presented as mean ± SD (n = 3 animals per time point).

Figure 1

Fig. 2. Analysis of Müller cell marker expression. (A) CRALBP expression (green) did not change after the MNU-treatment. (B) GFAP expression (red) was only detectable in astrocytes and Müller cell endfeet in control retinas and 1 day PI, but was strongly increased 3 and 7 days PI. Nuclei were counterstained with TO-PRO3. Scale bars indicate 20 µm. GCL: ganglion cell layer, INL: inner nuclear layer, ONL: outer nuclear layer. (C) Cralbp mRNA expression did not significantly change after the MNU-treatment. (D) Gfap mRNA expression was significantly upregulated 5 (***; P < 0.001) and 7 (*; P < 0.05) days PI. The mRNA expression was normalized to the expression of the reference gene Gapdh and control samples. Data are presented as mean ± SD (n = 3 animals per time point, repeated in three independent experiments).

Figure 2

Fig. 3. Quantification of SOX9-positive cells. Nuclei located in the INL and immunopositive for the Müller cell marker SOX9 were quantified in control retinas and 1 and 3 days PI. No significant changes in the number of SOX9-positive cells were observed. Data are presented as mean ± SD (n = 3 animals per time point).

Figure 3

Fig. 4. Patch clamp whole cell records of Müller cells from MNU-treated mice. (A) Representative examples of membrane currents of a control cell, (B) 3 days PI, (C) 5 days PI, and (D) 7 days PI. Depolarizing and hyperpolarizing voltage steps were applied in increments of 20 mV from a holding potential of −80 mV. Inward currents were absent in the presence of Ba2+ ions (n ≥ 15 cells and three animals per time point).

Figure 4

Fig. 5. Müller cell membrane properties after MNU-treatment. (A) The membrane potential was not significantly altered after MNU-treatment. (B) Membrane capacitance was significantly increased at all time points analyzed. (C) K+ currents at −60 mV hyperpolarization were not significantly altered. (D) Current density was significantly decreased at d3, d5 and d7 PI. Data are presented as mean ± SD and significance was reached with P < 0.005 (**) or P < 0.001 (***) vs. control (n ≥ 15 cells and three animals per time point).

Figure 5

Fig. 6. (A) Analysis of Kir4.1 mRNA expression. Relative gene expression was significantly downregulated at d3, d5, and d7 PI. The mRNA levels were normalized against Gapdh. Data are presented as mean ± SD and significance was reached with P < 0.05 (*) or P < 0.001 (***). (B) Immunohistochemical analysis of Kir4.1 expression. In control retinas, Kir4.1 was expressed around blood vessels and at the inner limiting membrane. The same expression pattern was maintained after the MNU-treatment. GCL: ganglion cell layer, INL: inner nuclear layer, ONL: outer nuclear layer. Scale bar indicates 20 µm (n = 3 animals per time point, repeated in 3 independent experiments).